News & Events

Dr. Ziad Ali, is one of the top cardiologists, holding a wonderful reputation worldwide. We at Symbiosis HVS Hospitals are proud to welcome him. Here are a few glimpses of Dr. Ankur Phararpekar (Director at Symbiosis HVS Hospitals) welcoming Dr. Ziad Ali.

Dr. Ziad Ali is the Director of the DeMatteis Cardiovascular Institute, Director of Investigational Interventional Cardiology, and Director of the Cardio-renal Program at St. Francis Hospital and Heart Center in New York.

Dr. Ali’s research interests focus on the use of advanced imaging and physiology technologies to optimize stent implantation, with a particular interest in how these modalities protect patients from kidney injury by sparing or eliminating the need for contrast.

Dr. Ali serves on the Editorial boards of three major cardiovascular journals and conducts peer reviews regularly for over 20 journals. Dr. Ali also writes the curriculum for the American College of Cardiology. 

Dr. Ali has been and is the Global Principal Investigator of multiple multicenter randomized trials.

Dr. Ali developed the Resting Full-Cycle Ratio (RFR) (Abbott, Santa Clara, CA), a technology that allows interventional cardiologists to determine whether heart artery blockages warrant treatment with stents or are better served with conservative management.

Dr. Ali was instrumental in the development of intravascular lithotripsy (Shockwave Medical, Santa Clara, CA), a technology that uses the age-old technique of breaking kidney stones with electrical energy, to allow treatment of calcium buildup in the heart arteries.

Dr. Ali developed pioneering techniques to perform coronary angiography with less than a tablespoon of contrast (≈10mL) (ultra-low contrast angiography), protecting patients with advanced kidney disease from the contrast associated with acute kidney injury and the potential need for dialysis.

By using his expertise in intravascular imaging and physiology, Dr. Ali established the techniques to perform vascular interventions, including arterial stent placement, completely free of contrast administration.

Dr. Ankur Phatarpekar & entire team of Symbiosis HVS Hospitals welcome the leading cardiologist of Japan, Dr. Takashi Akasaka with honor.

Dr. Akasaka graduated from Wakayama Medical University in 1982 and finished his residency at Kobe City Medical Center General Hospital (KCGH).

He had been a clinical fellow at Harefield Hospital in the United Kingdom in 1987. From 1989, he did clinical research work in coronary physiology using coronary flow velocity and pressure extensively at KCGH as a director of the cardiac catheterization laboratory for 8 years.

After he moved to Kawasaki Medical University as an associate professor, he started OCT for 5 years. And then, he became a Professor at Wakayama Medical University in 2005 and has been devoted to clinical research work using OCT and coronary physiology. He has published many papers regarding coronary imaging using OCT in addition to coronary physiology research.

Based on his clinical and research work, he has been the executive board member in various cardiology societies and the course co-directors of several coronary live-demonstration courses around the world.

We at Symbiosis HVS Hospitals are proud to have welcomed this great name in the field of interventional cardiology with honor & dignity.